tiprankstipranks
AmeriCann Inc (ACAN)
OTHER OTC:ACAN
US Market

AmeriCann (ACAN) Stock Price & Analysis

106 Followers

ACAN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.05 - $0.42
Previous Close$0.07
Volume1.20K
Average Volume (3M)13.82K
Market Cap
$1.52M
Enterprise Value$9.43M
Total Cash (Recent Filing)$807.61K
Total Debt (Recent Filing)$8.71M
Price to Earnings (P/E)-5.7
Beta-0.55
Feb 20, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding24,391,961
10 Day Avg. Volume3,613
30 Day Avg. Volume13,816
Standard Deviation0.38
R-Squared0.04
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.27
Price to Sales (P/S)0.65
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.22
Enterprise Value/Gross Profit3.72
Enterprise Value/Ebitda22.94
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.00%0.43%99.57%
0.00%
Insiders
0.00%
Mutual Funds
0.43% Other Institutional Investors
99.57% Public Companies and
Individual Investors

ACAN FAQ

What was AmeriCann Inc’s price range in the past 12 months?
AmeriCann Inc lowest stock price was $0.05 and its highest was $0.41 in the past 12 months.
    What is AmeriCann Inc’s market cap?
    Currently, no data Available
    When is AmeriCann Inc’s upcoming earnings report date?
    AmeriCann Inc’s upcoming earnings report date is Feb 20, 2024 which is 60 days ago.
      How were AmeriCann Inc’s earnings last quarter?
      AmeriCann Inc released its earnings results on Dec 19, 2023. The company reported -$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.006.
        Is AmeriCann Inc overvalued?
        According to Wall Street analysts AmeriCann Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does AmeriCann Inc pay dividends?
          AmeriCann Inc does not currently pay dividends.
          What is AmeriCann Inc’s EPS estimate?
          AmeriCann Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does AmeriCann Inc have?
          AmeriCann Inc has 24,391,960 shares outstanding.
            What happened to AmeriCann Inc’s price movement after its last earnings report?
            AmeriCann Inc reported an EPS of -$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of AmeriCann Inc?
              Currently, no hedge funds are holding shares in ACAN
              ---

              AmeriCann Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -69.09%
              12-Months-Change

              Fundamentals

              Return on Equity
              -5.10%
              Trailing 12-Months
              Asset Growth
              -1.59%
              Trailing 12-Months

              Company Description

              AmeriCann Inc

              Americann, Inc. is engaged in the development of medical cannabis cultivation and processing properties. Its projects include Denver Medical Cannabis Center, Massachusetts Medical Cannabis Center, and Illinois Medical Cannabis Center. The company was founded by Benjamin J. Barton on June 25, 2010 and is headquartered in Denver, CO.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Innovative Industrial Properties
              CNBX Pharmaceuticals
              Evoke Pharma
              Grapefruit USA
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis